NDMA requests 90-day comment extension on proposed OTC labeling reg.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABELING REVISION COSTS AND TIME UNDER REVIEW in a survey of OTC manufacturers being conducted by the Nonprescription Drug Manufacturers Association in response to FDA's recently proposed OTC drug labeling regulation. In an April 14 letter to the agency, NDMA requests a 90-day extension to the comment period for the proposed ruling. Comments currently are due by June 27.